Pyxis Oncology, Inc

This early-stage study is testing a new drug called PYX-201 in combination with an existing immunotherapy (pembrolizumab) for people with advanced solid tumors. The main goals are to find the safest and most effective dose and to see how well the body handles the two drugs togeth…

This is the first study in people to test a new cancer drug called PYX-201. Researchers want to find a safe and effective dose for adults with advanced solid tumors that have spread or returned after other treatments. The study will also look for early signs that the drug can shr…